We are live on ! Find out more
FCM

Frontier Capital Management Portfolio holdings

AUM $9.73B
1-Year Est. Return 55.65%
This Fund
S&P 500
This Quarter Est. Return
-16.16%
1 Year Est. Return
+55.65%
3 Year Est. Return
+154.46%
5 Year Est. Return
+213.15%
10 Year Est. Return
+1,202.39%
AUM
$12.4B
AUM Growth
-$3.14B
Cap. Flow
-$277M
Cap. Flow %
-2.23%
Top 10 Hldgs %
14.24%
Holding
306
New
19
Increased
87
Reduced
180
Closed
19

Top Buys

Rank Stock Value
1
XLNX
Xilinx Inc
XLNX
+$87.5M
2
KBR icon
KBR
KBR
+$83.4M
3
SGEN
Seagen Inc. Common Stock
SGEN
+$66.2M
4
NTNX icon
Nutanix
NTNX
+$61.6M
5
BURL icon
Burlington
BURL
+$56.3M

Sector Composition

Rank Sector Weight
1 Technology 20.08%
2 Industrials 17.14%
3 Consumer Discretionary 14.05%
4 Healthcare 13.97%
5 Financials 11.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BL icon
251
BlackLine
BL
$1.9B
$7.03M 0.06%
171,601
+39,375
+30% +$1.67M
CMP icon
252
Compass Minerals
CMP
$1.23B
$6.94M 0.06%
+166,441
New +$8.76M
AMD icon
253
Advanced Micro Devices
AMD
$700B
$6.88M 0.06%
+372,727
New +$8.06M
GMS
254
DELISTED
GMS Inc
GMS
$6.75M 0.05%
+454,141
New +$7.97M
GSM icon
255
FerroAtlántica
GSM
$590M
$6.28M 0.05%
3,948,536
-1,193,091
-23% -$5.71M
MASI
256
DELISTED
Masimo
MASI
$6.16M 0.05%
57,376
-19,855
-26% -$2.21M
PTCT icon
257
PTC Therapeutics
PTCT
$6.18B
$6.15M 0.05%
179,179
-324,838
-64% -$11.7M
AMWD
258
DELISTED
American Woodmark
AMWD
$5.96M 0.05%
107,000
+65,278
+156% +$4.16M
TXMD icon
259
TherapeuticsMD
TXMD
$23.8M
$5.7M 0.05%
+29,923
New +$7.3M
SGMO
260
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$5.09M 0.04%
443,386
-7,770
-2% -$96.5K
NE
261
DELISTED
Noble Corporation
NE
$5.01M 0.04%
1,913,215
+32,632
+2% +$155K
MEDP icon
262
Medpace
MEDP
$16.3B
$4.78M 0.04%
90,352
-29,017
-24% -$1.59M
STRA icon
263
Strategic Education
STRA
$1.98B
$4.77M 0.04%
+42,054
New +$5.36M
INVX
264
Innovex International
INVX
$1.8B
$4.49M 0.04%
149,534
-2,662
-2% -$107K
LOXO
265
DELISTED
Loxo Oncology, Inc
LOXO
$4.44M 0.04%
31,728
-19,814
-38% -$3.01M
HA
266
DELISTED
Hawaiian Holdings, Inc.
HA
$4.29M 0.03%
162,342
-1,736
-1% -$58.8K
AERI
267
DELISTED
Aerie Pharmaceuticals
AERI
$4.11M 0.03%
113,873
-439,372
-79% -$20.6M
ETSY icon
268
Etsy
ETSY
$8.12B
$4.1M 0.03%
+86,134
New +$4.05M
HR icon
269
Healthcare Realty
HR
$7.56B
$3.96M 0.03%
156,474
-73,310
-32% -$1.94M
QUIK icon
270
QuickLogic
QUIK
$211M
$3.6M 0.03%
350,567
-57,150
-14% -$736K
CDE icon
271
Coeur Mining
CDE
$15.1B
$3.52M 0.03%
787,249
-100,507
-11% -$475K
WGO icon
272
Winnebago Industries
WGO
$900M
$3.19M 0.03%
+131,889
New +$3.5M
VRAY
273
DELISTED
ViewRay, Inc.
VRAY
$2.82M 0.02%
463,869
-318,202
-41% -$2.38M
AMRN
274
Amarin Corp
AMRN
$297M
$2.81M 0.02%
10,306
-8,186
-44% -$2.98M
PVTL
275
DELISTED
Pivotal Software, Inc.
PVTL
$2.64M 0.02%
+161,264
New +$2.89M

Similar funds

Frontier Capital Management's Q4 2018 Portfolio in Review

As of Q4 2018, Frontier Capital Management held 306 positions worth $12.4B, down 20% from $15.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Frontier Capital Management's Q4 2018 filing shows 19 new, 87 increased, 180 reduced and 19 closed positions. Its largest new stake was Xilinx Inc: 1,046,508 shares worth $89.1M. The largest sale was TESARO, Inc., an estimated $129M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Frontier Capital Management's largest Q4 2018 buy was Xilinx Inc: 1,046,508 shares worth $89.1M.
  • Frontier Capital Management added most to KBR in Q4 2018, an estimated $83.4M increase.
  • Frontier Capital Management's biggest Q4 2018 reduction was TESARO, Inc., cutting an estimated $129M.
  • Frontier Capital Management fully exited Dollar Tree in Q4 2018, selling an estimated $68.6M.
  • Frontier Capital Management's ten largest holdings make up 14% of its $12.4B portfolio in Q4 2018.
  • Frontier Capital Management opened 19 new positions and closed 19 in Q4 2018.
  • Frontier Capital Management's portfolio value fell 20% quarter-over-quarter to $12.4B.

Based on Frontier Capital Management's 13F filing for Q4 2018, filed 25 Jan 2019.